Medicare Enrolled
Dr. Asad Khan, D.O
Pain Medicine · Richardson, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khan
Dr. Asad Khan is a pain medicine specialist in Richardson, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Khan performed 5,476 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khan received a total of $6,065 from 37 pharmaceutical and/or device companies across 346 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 11% volume in TX
$6,065 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,476
Medicare services
Top 11% in TX for pain medicine
Not available
Unique patients (not deduplicated)
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
964 | $89 | $254 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
640 | $0 | $1 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
593 | $31 | $94 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
501 | $189 | $402 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
500 | $60 | $162 |
| Contrast dye for imaging, lower concentration | 441 | $0 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
290 | $65 | $180 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
258 | $8 | $22 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
231 | $9 | $25 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
188 | $193 | $758 |
| Injection, methylprednisolone acetate, 40 mg | 86 | $6 | $14 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
80 | $52 | $169 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
78 | $184 | $679 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
78 | $96 | $345 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
75 | $37 | $99 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
61 | $74 | $221 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
55 | $119 | $379 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
48 | $39 | $141 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
44 | $439 | $1,529 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
42 | $245 | $657 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
39 | $85 | $180 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
34 | $10 | $31 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
32 | $62 | $167 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
28 | $185 | $758 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
27 | $202 | $741 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
20 | $89 | $378 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $39 | $112 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
13 | $185 | $654 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
13 | $94 | $328 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$6,065
Total received (2018-2024)
Avg $866/year across 7 years
Top 35% in TX for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
346
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,059
2023
$720
2022
$596
2021
$935
2020
$932
2019
$1,271
2018
$552
Payments by company (2024)
Boston Scientific Corporation
$319
Collegium Pharmaceutical, Inc.
$209
Forte Bio-Pharma LLC
$175
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$108
Abbott Laboratories
$59
PFIZER INC.
$47
Medtronic, Inc.
$38
SCILEX PHARMACEUTICALS INC.
$35
Saluda Medical Americas, Inc.
$28
Averitas Pharma Inc.
$23
ABBVIE INC.
$16
Top 3 companies account for 66.4% of 2024 payments
All-time payments by company (2018-2024) ›
Collegium Pharmaceutical, Inc.
$1,092
Nevro Corp.
$765
Abbott Laboratories
$563
Forte Bio-Pharma LLC
$547
Boston Scientific Corporation
$416
Medtronic USA, Inc.
$408
Scilex Pharmaceuticals Inc.
$285
Horizon Therapeutics plc
$256
PFIZER INC.
$188
ABBVIE INC.
$176
Xtant Medical Inc
$162
BioDelivery Sciences International, Inc.
$161
SCILEX PHARMACEUTICALS INC.
$159
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$142
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$132
Medtronic, Inc.
$111
BOSTON SCIENTIFIC CORPORATION
$50
Assertio Therapeutics, Inc.
$38
Horizon Pharma plc
$32
Avanos Medical
$31
ARBOR PHARMACEUTICALS, INC.
$30
Arbor Pharmaceuticals, Inc.
$29
Saluda Medical Americas, Inc.
$28
Shionogi Inc
$27
Allergan, Inc.
$26
Biohaven Pharmaceuticals, Inc.
$25
Averitas Pharma Inc.
$23
Siemens Medical Solutions USA, Inc.
$21
ASSERTIO THERAPEUTICS, Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
Zyla Life Sciences, Inc.
$18
Orthogenrx Inc.
$16
Azurity Pharmaceuticals, Inc.
$15
Sentynl Therapeutics, Inc.
$14
Biohaven Pharmaceutical Holding Company Ltd.
$13
Almatica Pharma LLC
$13
DePuy Synthes Sales Inc.
$13
Top 3 companies account for 39.9% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · Amitiza · BELBUCA · BOTOX · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · Cambia · Cios Select · DUEXIS · Edarbyclor · Evoke · GENERAL PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GenVisc 850 · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON Balloon Kyphoplasty · LYRICA · Levorphanol · NALOCET · NAPRELAN · NURTEC ODT · Nalocet · Nucynta · Nucynta ER · OCTRODE · ORTHOVISC · OSTEOCOOL RF ABLATION · Octrode SCS Leads · Omnia · PENNSAID · PROCLAIM · PROLATE · Proclaim IPG · QULIPTA · QUTENZA · RAYOS · RELISTOR · RELISTOR ORAL · SCS IPGs · SPECTRA WAVEWRITER · SPRIX · Senza Spinal Cord Stimulation System · Symproic · TRIVISC SODIUM HYALURONATE · UBRELVY · Varithena Administration Pack · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pain medicines in nearby ZIP areas
96
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY PLANO
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khan is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khan performed 964 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khan receive payments from pharmaceutical companies?
Yes. Dr. Khan received a total of $6,065 from 37 companies across 346 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khan's costs compare to other pain medicines in Richardson?
Dr. Khan's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Richardson
Browse pain medicines in Richardson ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in TX
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in TX
Which TX pain medicines receive the most from drug and device companies.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology